DI MARIO, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 6.699
EU - Europa 2.166
AS - Asia 1.374
AF - Africa 55
SA - Sud America 43
OC - Oceania 7
Totale 10.344
Nazione #
US - Stati Uniti d'America 6.647
UA - Ucraina 659
SG - Singapore 571
SE - Svezia 493
IN - India 427
CN - Cina 339
FI - Finlandia 265
IT - Italia 265
NL - Olanda 118
DE - Germania 97
IE - Irlanda 69
GB - Regno Unito 68
CA - Canada 44
BG - Bulgaria 42
TG - Togo 42
RU - Federazione Russa 39
AR - Argentina 34
BE - Belgio 18
RO - Romania 10
TR - Turchia 10
ZA - Sudafrica 8
JP - Giappone 7
MX - Messico 7
CH - Svizzera 6
AU - Australia 5
CL - Cile 5
MY - Malesia 5
LT - Lituania 4
CZ - Repubblica Ceca 3
LV - Lettonia 3
SA - Arabia Saudita 3
SC - Seychelles 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
FR - Francia 2
HK - Hong Kong 2
ID - Indonesia 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AT - Austria 1
BR - Brasile 1
DZ - Algeria 1
GR - Grecia 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 10.344
Città #
Chandler 696
Fairfield 671
Woodbridge 471
Singapore 398
Ann Arbor 377
Houston 368
Dearborn 335
Ashburn 316
Jacksonville 265
Princeton 257
Wilmington 252
Plano 241
Seattle 238
Santa Clara 222
Cambridge 161
Beijing 148
Boston 145
Des Moines 111
Lawrence 78
San Diego 76
Rome 75
Andover 74
Boardman 74
Dublin 69
San Paolo di Civitate 69
Millbury 43
Lomé 42
Sofia 41
Norwalk 40
Falls Church 37
Toronto 35
Federal 34
Hefei 28
Helsinki 25
San Mateo 25
Nanjing 24
Falkenstein 22
New York 22
Fremont 21
Auburn Hills 19
Moscow 19
Brussels 18
Kunming 18
Bühl 15
Bremen 13
Los Angeles 13
Nanchang 13
Guangzhou 11
Jinan 11
Mannheim 11
Frankfurt am Main 10
Milan 10
Ningbo 8
Redmond 7
Buffalo 6
Fuzhou 6
Istanbul 6
London 6
Muizenberg 6
Philadelphia 6
Zhengzhou 6
Florence 5
Laurel 5
Montréal 5
Padova 5
Shenyang 5
Bern 4
Changsha 4
Chengdu 4
Chongqing 4
Grafing 4
Hangzhou 4
Karabaglar 4
Kumar 4
Quzhou 4
Reston 4
Shaoxing 4
Tolfa 4
Hebei 3
Otoricho 3
Prague 3
Redwood City 3
Riga 3
Riva 3
Selva 3
Albanella 2
Auckland 2
Bari 2
Bengaluru 2
Dallas 2
Edinburgh 2
Guiyang 2
Hong Kong 2
Jakarta 2
Jiaxing 2
Kiribatake 2
La Paz 2
Leawood 2
Mexico City 2
Monteroni di Lecce 2
Totale 6.988
Nome #
Early detection of small-fiber neuropathy in diabetes: a laser-induced pain somatosensory-evoked potentials and pupillometric study 121
The G-308A variant of the Tumor Necrosis Factor-α (TNF-α) gene is not associated with obesity, insulin resistance and body fat distribution 99
PRODOTTI TARDIVI DELLA GLICAZIONE NON ENZIMATICA (AGE) IN PROTEINE A LUNGA EMIVITA IN CORSO DI DIABETE MELLITO SPERIMENTALE. 99
Association of the human adiponectin gene and insulin resistance 98
Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in Italian population 89
Accelerated diabetic glomerulopathy in galectin-3/age-receptor-3 knockout mice 87
Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a Caucasian population: are these Type 1b diabetes cases? 87
ABNORMALITIES OF COGNITIVE FUNCTIONS IN IDDM REVEALED BY P300 EVENT-RELATED POTENTIALS ANALYSIS. 86
HIGH GLUCOSE INHIBITS CYTOSOLIC CALCIUM SIGNALING IN CULTURED RAT MESANGIAL CELLS 85
Echocardiographic Epicardial Adipose Tissue Is Related to Anthropometric and Clinical Parameters of Metabolic Syndrome: A New Indicator of Cardiovascular Risk 84
EARLY DETECTION OF NEUROLOGICAL INVOLVEMENT DURING DIABETES: A COMPARISON OF ELECTROPHYSIOLOGICAL DATA AND BIOCHEMICAL ASPECTS. 82
Expression of Activated Notch3 in Transgenic Mice Enhances Generation of T Regulatory Cells and Protects against Experimental Autoimmune Diabetes 81
Pathogenetic mechanisms of diabetic microangiopathy 78
Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production 77
Role of galectin-3 in diabetic nephropathy. 76
Radioiodinated recombinant human TSH: A novel radiopharmaceutical for thyroid cancer metastases detection 74
DIABETIC NEPHROPATHY. MONITORING THE EARLY STAGES WITH NEW SENSITIVE ASSAYS FOR URINARY ALBUMIN AND IMMUNOGLOBULIN G. 73
Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice 73
A sensitive routine assay for urinary albumin based on the competitive binding to antialbumin antibodies in solid phase 73
Defective lymphocyte caspase-3 expression in type 1 diabetes mellitus 73
Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy 72
Angiotensin-converting enzyme inhibition modulates high glucose-induced extracellular matrix changes in mouse glomerular epithelial cells. 71
The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or up regulating galectin-3 expression. 71
Alteration in extracellular matrix synthesis induced by high glucose can be modified by angiotensin converting enzyme inhibitors: an in vivo study. 69
15th Golgi Lecture: From Hyperglycaemia to the Dysregulation of Vascular Remodelling in Diabetes 69
Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation 69
EARLY EVALUATION OF DIABETIC NEUROPATHY AND NEPHROPATHY IN TYPE 1 DIABETIC PATIENTS: NEUROPHYSILOGICAL AND BIOCHEMICAL CORRELATES. 68
Advanced glycation end-product levels in eye lens proteins and aotic and tail tendon collagen in primary and early or late secondary transplanted diabetic inbred Lewis rats. 68
IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study 68
Characterization of proteinuria in experimental diabetes mellitus. 67
The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance 67
Tissue transglutaminase autoantibody detection in human saliva: a powerful method for celiac disease screening 66
Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease 66
EARLY STAGES OF DIABETIC NEPHROPATHY. NEW SENSITIVE ASSAYS FOR URINARY ALBUMIN AND IMMUNOGLOBULIN G TO MONITOR INITIAL KIDNEY DAMAGE. 65
The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region) 65
D-lysine as inhibitor of in vitro non-enzymic glycation of serum and structural proteins: its possible relevance in the pathogenesis of late diabetic complications. 65
Early stages of diabetic nephropathy: evaluation by a new sensitive assay for urinary albumin and immunoglobulin G. 64
Development of diabetic nephropathy in the Milan normotensive strain, but not in the Milan hypertensive strain: Possible permissive role of hemodynamics 64
Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels 64
Enhanced nonenzymatic glycation of eye lens proteins in experimental diabetes mellitus: an approach for the study of protein alterations as mediators of normal aging phenomena 64
Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C 64
Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study) 63
Function of pancreatic islets isolated from a type 1 diabetic patient. 63
Modulazione della sintesi di matrice extracellulare da parte di inibitori dell'angiotensin converting enzyme in colture di cellule epiteliali renali. 62
Multimodal evoked potentials related to metaboliccontrol in diabetes mellitus. 62
INFLUENCE OF CAPTOPRIL ON KIDNEY PROTEIN PERMSELECTIVITY IN HYPERTENSIVE DIABETIC PATIENTS. 62
A NEW METHOD FOR THE DETECTION OF HUMAN IGG1 AND IGG4 IN SERA AND URINE: AN INDEX FOR CHARGE PERMSELECTIVITY MODIFICATION IN DIABETIC PATIENTS. 62
NEW PARAMETERS TO MONITOR THE PROGRESSION OF DIABETIC NEPHROPATHY 62
Reduced formation of the early Amadori products induced by D-lysine treatment in experimental diabetes. 61
Markers di autoimmunità e complicanze neurologiche nel diabete di tipo 2. 61
Reduced formation of Advanced Glycation End Products induced by D-Lysine: preliminary in vitro observations 61
The Gly972 → Arg IRS-1 variant is associated with type 1 diabetes in continental Italy 61
Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies 60
Neuroelectrophysiological alterations in experimental diabetes mellitus. 59
ESCREZIONE DI IMMUNOGLOBULINE ANIONICHE E CATIONICHE E PERMSELETTIVITA'DELLA FILTRAZIONE GLOMERULARE. 58
P300 EVENT-RELATED POTENTIAL REVEALS ABNORMALITIES OF COGNITIVE FUNCTIONS IN IDDM. 58
KIDNEY PROTEIN PERMSELECTIVITY IN TYPE 2 DIABETES MELLITUS. 58
Aumentata espressione di poly-ADP ribosio polymerasi in mononucleati circolanti di pazienti con diabete di tipo 2 57
Protein charge permselectivity in diabetic nephropathy. 57
The common PPAR-gamma 2 Pro12Ala variant is associated with greater insulin sensitivity 56
Glomerular cell replication and cell loss through apoptosis in experimental diabetes mellitus 56
Effect of islet transplantation on neuroelectrophysiological abnormalities in diabetic inbred Lewis rats: comparison of primary versus secondary prevention 56
CHARGE SELECTIVITY OF PROTEINURIA IN TYPE 1 DIABETES EXPLORED BY IMMUNOGLOBULIN SUBCLASS CLEARANCE. 55
Urinary IgG4: an additional parameter in characterizing patients with stage III diabetic nephropathy. 55
Mechanisms of glucose-enhanced accumulation of extracellular matrix in glomerular mesangial cells. 55
Linfociti T attivati nella gravidanza normale e diabetica. 54
REVERSIBILITY OF NEUROELECTROPHYSIOLOGICAL ABNORMALITIES IN transplanted diabetic rats. 54
Pre-perceptual pain sensory responses (N1 component) in type 1 diabetes mellitus. 54
Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor. 54
Regression of neurophysiological abnormalities in experimental diabetes after islet tranplantation. 53
ENHANCED NONENZYMATIC GLYCATION OF PROTEINS IN DIABETES MELLITUS: A NEW APPROACH FOR THE STUDY OF PROTEIN ALTERATIONS AS MEDIATORS OF NORMAL AGING PHENOMENA 53
High glucose level inhibits capacitative Ca2+ influx in cultured rat mesangial cells by a protein kinase C-dependent mechanism 53
Ablation of the p66Shc longevity gene provides protection towards experimental diabetic glomerulopathy in mice. 53
Abnormalities of cognitive functions in IDDM revealed by P300 Event-Related Potential Analysis 53
Association of beta2 adrenergic receptor polymorphisms and related haplotypes with triglycerides and ldl-cholesterol levels in obese subjects 52
TRAPIANTO DI INSULE PANCREATICHE A TEMPI DIFFERENTI DALLA COMPARSA DI DIABETE: EFFETTO SULLA GLICAZIONE NON ENZIMATICA IN TESSUTI BERSAGLIO DI COMPLICANZE DIABETICHE. 52
A NEW SENSITIVE SANDWICH TECHNIQUE FOR URINARY IMMUNOGLOBULIN G USING MONOCLONAL AND/OR POLYCLONAL ANTIBODIES. 51
Electrophysiological alterations of the central nervous system in diabetes mellitus. 51
Perdita della differenza clino/ortostatismo della albuminuria caratteristica dei diabetici senza segni di nefropatia. 50
SOTTOPOPOLAZIONI LINFOCITARIE, CELLULE T ATTIVATE E IMMUNOCOMPLESSI CIRCOLANTI IN PAZIENTI DIABETICI CON E SENZA MICROALBUMINURIA. 50
Mechanisms of glucose-induced extracellular matrix overproduction by cultured vascular cells 50
Ganglioside antigens in autoimmune diabetes 50
SELECTIVE CHANGES IN IGG4 AND/OR IGG URINARY EXCRETION INDUCED BY PHYSICAL EXERCISE, AMINOACID LOAD, HYPOTENSIVE AGENTS IN NORMAL AND DIABETIC SUBJECTS. 1ST WORKSHOP ON BLOOD PRESSURE AND DIABETIC NEPHROPATHY: PATHOGENESIS AND TREATMENT. 49
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse 49
Gangliosides and autoimmune diabetes 49
A new sensitive assay for urinary immunoglobulin G based on competitive binding. 48
Human resistin gene, obesity, and type 2 diabetes - Mutation analysis and population study 48
Early detection of neurological involvement in type 1 and type 2 diabetes: Multimodal evoked potentials versus metabolic control. 48
Purinergic modulation of mesangial extracellular matrix production: Role in diabetic and other glomerular diseases 48
Studio dei potenziali evocati visivi ed auditivi nel diabete tipo I e II 47
null 47
THE DIFFERENT RENAL DESTINIES OF ANIONIC AND CATIONIC IMMMUNOGLOBULINS GIVE INSIGHT IN THE PATHOPHYSIOLOGY OF KIDNEY CHARGE PERMSELECTIVITY. 47
Looking for additional markers to monitor diabetic nephropathy: A new ELISA using monoclonal antibodies for the detection of IgG. 47
Diabetic complications: is there a way out of the labyrinth? 47
Up-regulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end-products via a receptor-mediated mechanism. 47
LIVELLI DI AGE (ADVANCED GLYCATION ENDPRODUCTS) NEL CRISTALLINO E NEL COLLAGENE CAUDALE DOPO TRAPIANTO INSULARE IN RATTI LEWIS CON DIFFERENTE DURATA DI DIABETE. 47
PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity. 47
La Nefropatia Diabetica. 46
La variante Pro12Ala del gene PPAR-γ2 è associata con un maggiore grado di insulino-sensibilità. 46
Role of oxidative stress and protein kinase C activation in the increased retinal endothelial cell monolayer permeability induced by the diabetic milieu 46
Totale 6.261
Categoria #
all - tutte 32.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.444 0 0 0 0 0 444 305 251 167 172 66 39
2020/2021804 102 102 30 71 18 100 113 62 38 105 49 14
2021/20221.901 7 143 173 47 289 35 30 184 130 201 215 447
2022/20232.295 455 359 133 259 285 336 18 110 224 26 82 8
2023/2024704 59 122 18 61 59 77 11 29 6 96 64 102
2024/2025842 99 159 177 35 195 177 0 0 0 0 0 0
Totale 10.502